Evolving Treatment Options for Metastatic Renal Cell Carcinoma (mRCC)
Approximately a third of patients diagnosed with kidney cancer in the United States present with advanced disease and those who present with distant metastases historically had dismal 5-year relative survival. However, over the last several years, advancements have led to improved life expectancy an...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2023-04-01
|
| Schriftenreihe: | Uro |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2673-4397/3/2/14 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|